SF3B1 and myelodysplastic syndrome: Co-occurrence of SF3B1 mutation and del(5q) was a matter of debate in a recent publication of the International Working Group for the Prognosis of MDS [32], in which they provided evidence supporting the recognition of SF3B1-mutant MDS as a distinct entity.